1. Home
  2. UNCY vs DSY Comparison

UNCY vs DSY Comparison

Compare UNCY & DSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNCY
  • DSY
  • Stock Information
  • Founded
  • UNCY 2016
  • DSY 2020
  • Country
  • UNCY United States
  • DSY China
  • Employees
  • UNCY N/A
  • DSY N/A
  • Industry
  • UNCY Biotechnology: Pharmaceutical Preparations
  • DSY
  • Sector
  • UNCY Health Care
  • DSY
  • Exchange
  • UNCY Nasdaq
  • DSY Nasdaq
  • Market Cap
  • UNCY 74.2M
  • DSY 85.8M
  • IPO Year
  • UNCY 2021
  • DSY N/A
  • Fundamental
  • Price
  • UNCY $4.42
  • DSY $0.58
  • Analyst Decision
  • UNCY Strong Buy
  • DSY
  • Analyst Count
  • UNCY 5
  • DSY 0
  • Target Price
  • UNCY $41.60
  • DSY N/A
  • AVG Volume (30 Days)
  • UNCY 459.6K
  • DSY 240.8K
  • Earning Date
  • UNCY 11-14-2025
  • DSY 01-01-0001
  • Dividend Yield
  • UNCY N/A
  • DSY N/A
  • EPS Growth
  • UNCY N/A
  • DSY 120.37
  • EPS
  • UNCY N/A
  • DSY 0.01
  • Revenue
  • UNCY N/A
  • DSY $7,323,356.00
  • Revenue This Year
  • UNCY N/A
  • DSY N/A
  • Revenue Next Year
  • UNCY $19,392.60
  • DSY N/A
  • P/E Ratio
  • UNCY N/A
  • DSY $49.18
  • Revenue Growth
  • UNCY N/A
  • DSY 16.37
  • 52 Week Low
  • UNCY $3.71
  • DSY $0.58
  • 52 Week High
  • UNCY $11.00
  • DSY $7.33
  • Technical
  • Relative Strength Index (RSI)
  • UNCY 43.93
  • DSY 27.05
  • Support Level
  • UNCY $4.32
  • DSY $0.59
  • Resistance Level
  • UNCY $4.63
  • DSY $0.64
  • Average True Range (ATR)
  • UNCY 0.29
  • DSY 0.05
  • MACD
  • UNCY -0.08
  • DSY 0.01
  • Stochastic Oscillator
  • UNCY 12.61
  • DSY 0.33

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

About DSY Big Tree Cloud Holdings Limited Ordinary Shares

Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, and sales of personal care products and other consumer goods. In particular, it is focused on the development and production of feminine pads and other feminine hygiene products. Through its platform, the company focuses on high-quality product development, deep customer engagement, and efficient sales and marketing.

Share on Social Networks: